GlassScriptPhysician profile
Stanley K Yoo
NPI 1881808343
$1,678.91
in general payments reported to CMS, 2019-2025
8 companies · $25.93 in 2025
The $25.93 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.96 · 2023: $154 · 2024: $1,486 · 2025: $25.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,153 · Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,152.93 |
| Food and Beverage | $513.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $1,210.80 | 2024 | Iovera |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.66 | 2023-2024 | Relistor |
| Collegium Pharmaceutical, INC. | $93.63 | 2021-2024 | Xtampza |
| Protega Pharmaceutials INC | $78.83 | 2023-2024 | Roxybond |
| Azurity Pharmaceuticals, INC. | $69.27 | 2023-2024 | Horizant, Horizant |
| Scilex Pharmaceuticals INC. | $46.62 | 2023-2024 | Ztlido |
| Ipsen Biopharmaceuticals, INC | $25.93 | 2025 | Dysport |
| Abbvie INC. | $14.17 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.